Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.

Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.

Item
http://www.wikidata.org/entity/Q38812885
Serum Insulin-like Growth Factor I Quantitation by Mass Spectrometry: Insights for Protein Quantitation with this TechnologyTime-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats.In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate.Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation.2D-LC-MS/MS to measure cleaved high-molecular-weight kininogen in human plasma as a biomarker for C1-INH-HAE.Sensitive, High-Throughput, and Robust Trapping-Micro-LC-MS Strategy for the Quantification of Biomarkers and Antibody Biotherapeutics.Practical considerations in enhancing LC-MS sensitivity for therapeutic protein bioanalysis.Key considerations for LC-MS analysis of protein biotherapeutics in tissues.Mapping Protein-Protein Interactions Using Affinity Purification and Mass Spectrometry.
P2860

Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.

Item
http://www.wikidata.org/entity/Q38812885
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Qualitative and quantitative c ...... omatography mass spectrometry.
@en
type
label
Qualitative and quantitative c ...... omatography mass spectrometry.
@en
prefLabel
Qualitative and quantitative c ...... omatography mass spectrometry.
@en
P1433
P1476
P2093
P2860
P31
P356
P577
P698
P356
P1433
P1476
Qualitative and quantitative c ...... omatography mass spectrometry.
@en
P2093
P2860
P31
P356
P577
P698